Physician review
Prescription decisions begin with medical-history and contraindication review by Dr. Anjmun Sharma, MD.
✓ Medically reviewed by Dr. Anjmun Sharma, M.D., Updated May 2026
A Zepbound Alternative That Won't Break the Bank
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary.
zepbound alternativezepbound cliniccheaper than zepboundzepbound without insurancealternatives to zepbound
Quick answer
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. New Hope Weight Loss is not affiliated with Eli Lilly or the Zepbound brand; our cash-pay compounded tirzepatide programs start at $233 per month with no insurance required and a $119 telehealth consultation to begin.
Important: Compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical. Eligibility and results vary.
Costs less than a coffee and a pastry.
A coffee and a pastry~$9/day
Your weight-loss plan$7.70/day$54/week
$233 a month, physician-supervised, no insurance needed.
Why People Look for a Zepbound Alternative
Zepbound® is a registered trademark of Eli Lilly and Company and is approved by the FDA for specific uses. But for many people it's hard to get: list prices can exceed $1,000/month without insurance, coverage is inconsistent, and the 2024-2025 shortages showed how unreliable access can be. That's why so many search for a more accessible alternative.
New Hope Weight Loss is not affiliated with Eli Lilly and Company. The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary.
How the Compounded Option Compares
| Brand-name Zepbound | Compounded Tirzepatide at NHWL | |
|---|---|---|
| Active ingredient | Tirzepatide | Label identifies tirzepatide; separate compounded product |
| Typical monthly cost | $1,000+ (no insurance) | from $233/mo |
| Physician supervision | Varies | Always, Dr. Sharma |
| FDA-approved product | Yes | No (compounded) |
| Insurance required | Often | Never |
Compounded medications are not FDA-approved products, are not brand-identical, and results vary. Any prescription requires individualized medical review and lawful pharmacy fulfillment. Dr. Sharma will tell you honestly whether you're a good candidate.
What You Pay at New Hope Weight Loss
- $119 one-time, Dr. Sharma's review + first prescription.
- from $699 for a 3-month plan = $233/month.
- $199 one-month Skeptics Trial (compounded semaglutide) if you want to start small.
HSA/FSA accepted. Klarna and Affirm financing available. No insurance, ever.
Estimate Your Savings
Frequently asked questions
Is there a cheaper alternative to Zepbound?
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. Compounded medications are not FDA-approved and are not identical to the brand, but they are a legal, supervised, more accessible option.
Can I get Zepbound without insurance?
Brand-name Zepbound typically requires insurance or out-of-pocket payment exceeding $1,000/month. New Hope Weight Loss never requires insurance, compounded tirzepatide is cash-pay from $233/month with HSA/FSA accepted.
Is the compounded version the same as Zepbound?
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brand products, is not FDA-approved or brand-identical, and results vary. Any prescription requires Dr. Sharma's review and depends on lawful pharmacy fulfillment for the patient's location.
How do I switch from Zepbound to the compounded option?
Take our 2-minute quiz and complete the medical intake form. Tell Dr. Sharma about your current dose and history; she'll determine the right starting plan and supervise the transition.
Transparent pricing
$233/month
About $7.70 a day, less than a coffee and a pastry
A fraction of brand-name GLP-1 list prices, which often run $900 to $1,300 or more a month.
- Licensed U.S. physician, supervised the whole way
- Compounded tirzepatide included
- Only if a prescription is approved and the dispensing pharmacy can fulfill it for your location, the pharmacy confirms packaging and shipping details before fulfillment
- Ongoing dose adjustments and support
- No insurance needed, HSA and FSA plus financing accepted
$119 one-time to get started with your physician consultation.
Medical disclaimer: Individual results may vary. GLP-1 medications require a physician prescription and ongoing supervision. Clinical trial results cited are averages; not all patients achieve the same outcomes. Eligibility is determined during the medical consultation. This information does not replace professional medical advice.
New Hope Weight Loss | 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.
What Zepbound Is Approved to Treat: Body Weight and Sleep Apnea
Zepbound and Mounjaro contain the same molecule, tirzepatide, but the FDA approved them for different purposes, and Zepbound holds the two indications that matter most to someone focused on weight. Zepbound is approved, alongside a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain that reduction long term in adults with obesity, or in adults with overweight who also have at least one weight-related condition. In December 2024 the FDA added a second indication that no other semaglutide or tirzepatide product carries: treating moderate to severe obstructive sleep apnea in adults with obesity. Mounjaro, the same molecule under a different brand name, is approved to improve blood sugar control in adults and in pediatric patients 10 years and older with type 2 diabetes, not for weight management and not for sleep apnea.
Tirzepatide also differs from semaglutide, the molecule in Wegovy. Semaglutide activates one receptor, GLP-1. Tirzepatide activates two, GIP and GLP-1, which is why it is described as a dual receptor agonist rather than simply a GLP-1 medication.
Those FDA indications belong to Zepbound, not to a compounded product. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company, and New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Eli Lilly. The compounded preparation prescribed here and prepared by a licensed pharmacy is not FDA-approved, is not brand-identical, has not undergone FDA premarket review for safety, effectiveness, or quality, and is not approved to treat sleep apnea. Results vary, and Dr. Sharma evaluates candidacy individually.
Is Zepbound approved for sleep apnea, and does the compounded option treat sleep apnea?
Zepbound is FDA-approved to treat moderate to severe obstructive sleep apnea in adults with obesity, an indication granted in December 2024 that no other semaglutide or tirzepatide product carries. That approval applies to the brand product only. The compounded tirzepatide prescribed through New Hope Weight Loss is not FDA-approved for sleep apnea or for any other condition. Sleep apnea needs its own diagnosis, so tell Dr. Sharma if you have it.
Why is Zepbound approved for weight management when Mounjaro, the same drug, is not?
Approvals are granted per product and per indication, based on the studies a manufacturer submits for that product. Eli Lilly studied tirzepatide for chronic weight management and for obstructive sleep apnea under the Zepbound name, and for blood sugar control in type 2 diabetes under the Mounjaro name. Same molecule, separate applications, separate labels. Neither label describes or covers a compounded preparation.
Zepbound works on both GIP and GLP-1. Is that better than a GLP-1 alone?
Tirzepatide, the molecule in Zepbound, activates the GIP receptor and the GLP-1 receptor, while semaglutide, the molecule in Wegovy, activates GLP-1 alone. That is a real pharmacologic difference, but more receptors does not automatically mean a better outcome for you. Response, tolerability, and medical history vary from person to person, and no comparison between brand products predicts how anyone responds to a compounded preparation. Dr. Sharma reviews your history first.